Ledger.Open graph →
SEC Form D · filed November 23, 2016

Magenta Therapeutics, Inc

Offering
$48.7M
Sold
$17.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

David Scadden · CAMBRIDGE, MADirectorMichael Bonney · CAMBRIDGE, MADirectorAlexis Borisy · Cambrige, MADirectorBruce Booth · Waltham, MADirectorBastiano Sanna · CAMBRIDGE, MAExecThomas Daniel · CAMBRIDGE, MADirectorJason Gardner · Irvine, CAExec · DirectorDavid Scadden · CAMBRIDGE, MADirectorMichael Bonney · CAMBRIDGE, MADirectorBruce Booth · Cambridge, MADirectorAlexis Borisy · Boston, MADirectorBastiano Sanna · CAMBRIDGE, MAExecThomas Daniel · CAMBRIDGE, MADirectorJason Gardner · CAMBRIDGE, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗